Wikidata

(Q35894626)

English

Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?

scientific article published in October 2004

In more languages
default for all languages
No label defined

No description defined

Statements

title
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15382266
retrieved
11 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q35894626&oldid=1788952671"